Yesha Parekh

Ms. Yesha Parekh

Rutgers University RWJ Medical School

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Erin McDonnellErin McDonnell
Erin McDonnell
Nicole AltomareNicole Altomare
Nicole Altomare
Yesha ParekhYesha Parekh
Yesha Parekh
RGRam C. Gowda
Ram C. Gowda
PPPayal D. Parikh
Payal D. Parikh
MBMartin Blaser
Martin Blaser
Coronavirus 2019 (COVID-19) has been reported to trigger Guillain–Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here we describe a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient’s episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. We also consider the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, we recommend close observation for neurologic symptoms over the next days and weeks.

11 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Yesha ParekhYesha Parekh
Yesha Parekh
Nicole AltomareNicole Altomare
Nicole Altomare
Erin McDonnellErin McDonnell
Erin McDonnell
MBMartin Blaser
Martin Blaser
PPPayal D. Parikh
Payal D. Parikh
Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.